Skip to main content

Acadia Healthcare Company, Inc.

For the period ended Sep 30, 2026. Filed Nov 4, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 4, 2026

ACHC$38.64+0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Equity (Unaudited)

Condensed Consolidated Statements of Equity

(In thousands)

Common Stock · AdditionalPaid-in · Retained Earnings
SharesAmountCapital(Accumulated Deficit)Total
Balance at December 31, 202491,775$918$2,685,464$387,333$3,073,715
Common stock issued under stock incentive plans2172(2)——
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(1,936)—(1,936)
Repurchase of common stock, including excise tax(1,603)(16)—(47,256)(47,272)
Equity-based compensation expense——8,677—8,677
Net income attributable to Acadia Healthcare Company, Inc.———8,3748,374
Balance at March 31, 202590,3899042,692,203348,4513,041,558
Common stock issued under stock incentive plans1091(1)——
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(1,780)—(1,780)
Repurchase of common stock, including excise tax(104)(1)—(3,159)(3,160)
Equity-based compensation expense——10,549—10,549
Other——692—692
Net income attributable to Acadia Healthcare Company, Inc.———30,12730,127
Balance at June 30, 202590,3949042,701,663375,4193,077,986
Common stock issued under stock incentive plans38————
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(237)—(237)
Repurchase of common stock, including excise tax———99
Equity-based compensation expense——6,031—6,031
Other——262—262
Net income attributable to Acadia Healthcare Company, Inc.———36,24636,246
Balance at September 30, 202590,4329042,707,719411,6743,120,297
Common stock issued under stock incentive plans211(1)——
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(273)—(273)
Repurchase of common stock, including excise tax———44
Equity-based compensation expense——6,451—6,451
Net loss attributable to Acadia Healthcare Company, Inc.———(1,177,519)(1,177,519)
Balance at December 31, 202590,4539052,713,896(765,841)1,948,960
Common stock issued under stock incentive plans3113(3)——
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(2,744)—(2,744)
Equity-based compensation expense——7,956—7,956
Net income attributable to Acadia Healthcare Company, Inc.———4,1054,105
Balance at March 31, 202690,7649082,719,105(761,736)1,958,277
Common stock issued under stock incentive plans1041(1)——
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(1,063)—(1,063)
Equity-based compensation expense——10,990—10,990
Other——(10)—(10)
Net income attributable to Acadia Healthcare Company, Inc.———10,92810,928
Balance at June 30, 202690,8689092,729,021(750,808)1,979,122
Common stock issued under stock incentive plans44—70—70
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(413)—(413)
Equity-based compensation expense——9,246—9,246
Other——(19)—(19)
Net income attributable to Acadia Healthcare Company, Inc.———34,48634,486
Balance at September 30, 202690,912$909$2,737,905$(716,322)$2,022,492
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.